Arrowstreet Capital’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-469,032
| Closed | -$8.77M | – | 2638 |
|
|
2020
Q4 | $8.77M | Sell |
469,032
-112,664
| -19% | -$2.11M | 0.01% | 932 |
|
|
2020
Q3 | $9.88M | Buy |
581,696
+17,600
| +3% | +$299K | 0.02% | 846 |
|
|
2020
Q2 | $13.1M | Buy |
564,096
+401,096
| +246% | +$9.34M | 0.02% | 669 |
|
|
2020
Q1 | $1.37M | Sell |
163,000
-98,772
| -38% | -$830K | ﹤0.01% | 1203 |
|
|
2019
Q4 | $2.56M | Buy |
261,772
+39,150
| +18% | +$383K | 0.01% | 1059 |
|
|
2019
Q3 | $2.11M | Buy |
222,622
+31,324
| +16% | +$297K | ﹤0.01% | 972 |
|
|
2019
Q2 | $2.27M | Sell |
191,298
-21,796
| -10% | -$259K | 0.01% | 873 |
|
|
2019
Q1 | $3.75M | Sell |
213,094
-77,765
| -27% | -$1.37M | 0.01% | 889 |
|
|
2018
Q4 | $5.05M | Buy |
290,859
+114,754
| +65% | +$1.99M | 0.01% | 579 |
|
|
2018
Q3 | $2.62M | Buy |
176,105
+106,140
| +152% | +$1.58M | 0.01% | 646 |
|
|
2018
Q2 | $1.11M | Buy |
69,965
+7,380
| +12% | +$117K | ﹤0.01% | 781 |
|
|
2018
Q1 | $889K | Sell |
62,585
-14,218
| -19% | -$202K | ﹤0.01% | 891 |
|
|
2017
Q4 | $1.08M | Buy |
+76,803
| New | +$1.08M | ﹤0.01% | 946 |
|
|
2016
Q4 | – | Sell |
-104,650
| Closed | -$2.02M | – | 2658 |
|
|
2016
Q3 | $2.02M | Sell |
104,650
-7,959
| -7% | -$154K | 0.01% | 927 |
|
|
2016
Q2 | $2.2M | Buy |
112,609
+36,700
| +48% | +$716K | 0.01% | 812 |
|
|
2016
Q1 | $1.56M | Sell |
75,909
-44,000
| -37% | -$907K | 0.01% | 869 |
|
|
2015
Q4 | $2.46M | Buy |
119,909
+17,209
| +17% | +$353K | 0.01% | 745 |
|
|
2015
Q3 | $1.76M | Buy |
+102,700
| New | +$1.76M | 0.01% | 779 |
|
|
2014
Q4 | – | Sell |
-11,625
| Closed | -$206K | – | 1365 |
|
|
2014
Q3 | $206K | Buy |
+11,625
| New | +$206K | ﹤0.01% | 936 |
|
|
2013
Q4 | – | Sell |
-13,956
| Closed | -$330K | – | 1325 |
|
|
2013
Q3 | $330K | Buy |
+13,956
| New | +$330K | ﹤0.01% | 843 |
|